VOLORIDGE INVESTMENT MANAGEMENT, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 153 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2017. The put-call ratio across all filers is 2.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$271,632
-93.6%
170,838
-74.9%
0.00%
-95.8%
Q4 2022$4,233,472
+383.3%
679,530
+393.3%
0.02%
+380.0%
Q2 2022$876,000
-64.9%
137,744
-74.4%
0.01%
-64.3%
Q1 2022$2,496,000
-22.2%
537,856
-16.2%
0.01%
-22.2%
Q4 2021$3,210,000
+3.7%
642,035
+150.1%
0.02%
-10.0%
Q3 2021$3,094,000
+125.8%
256,761
+296.3%
0.02%
+122.2%
Q2 2021$1,370,000
+6.1%
64,794
+30.5%
0.01%
-18.2%
Q4 2020$1,291,000
+236.2%
49,643
+670.7%
0.01%
+57.1%
Q4 2019$384,000
+48.3%
6,441
+15.6%
0.01%0.0%
Q2 2019$259,000
-94.2%
5,571
-91.8%
0.01%
-92.8%
Q4 2017$4,455,000
-2.8%
67,666
-26.0%
0.10%
-4.9%
Q3 2017$4,585,000
-2.2%
91,480
-9.7%
0.10%
-12.8%
Q2 2017$4,689,000
+131.2%
101,319
+76.4%
0.12%
+138.8%
Q1 2017$2,028,000
-59.9%
57,435
-73.2%
0.05%
-79.4%
Q3 2015$5,052,000214,1620.24%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2017
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders